Quality ofrecovery with pericapsular nerve block with use of dexamethasone as an adjuvant
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2020/11/029303
- Lead Sponsor
- GGS MEDICAL COLLEGE AND HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA I-III
Scheduled for Hip surgeries
Exclusion Criteria
Patientâ??s refusal to give consent.
Coagulopathy.
Infection at the injection site.
Allergy to local anaesthetics.
Severe cardiopulmonary disease (>=ASA IV) diabetic or other neuropathies .
Patients receiving opioids for chronic analgesic therapy.
Inability to comprehend visual analogue scale (VAS)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the Quality of recovery (QoR) at 24 hrs postoperatively following Pericapsular nerve group block in Levobupivacaine +dexamethasone (Group D) <br/ ><br>To assess the Quality of recovery (QoR) at 24 hrs postoperatively following Pericapsular nerve group block in Levobupivacaine +normal saline .(Group C) <br/ ><br> To Compare Quality of recovery (QoR) of both Group D and Group C. <br/ ><br>Timepoint: To assess the Quality of recovery (QoR) at 24 hrs postoperatively following Pericapsular nerve group block in Levobupivacaine +dexamethasone (Group D) <br/ ><br>To assess the Quality of recovery (QoR) at 24 hrs postoperatively following Pericapsular nerve group block in Levobupivacaine +normal saline .(Group C) <br/ ><br> To Compare Quality of recovery (QoR) of both Group D and Group C. <br/ ><br>
- Secondary Outcome Measures
Name Time Method VAS will be measured at PACU , 2,4,8,12 and 24h. <br/ ><br>Cumulative opioid consumption at 24 hTimepoint: VAS at 2,4,8,12 and 24h <br/ ><br>Cumulative opioid at 24h